Corporate strategic investment in digital health at all-time high

Corporate, or "strategic," investors are busy making digital health investments in smaller companies as they seek to fortify their presence in that important space. So far 2014 boasts about 70 deals worth $800 million, easily exceeding last year's total. Deal volume is nearly double that of 2012. Since 2010 strategic players have made 210 deals totaling $2.34 billion. Qualcomm Ventures is the largest strategic investor, followed by Merck Global Health Innovation fund, BlueCross BlueShield Venture Partners and and Google Ventures. Other strategics in digital health: Intel ($INTC), Johnson & Johnson ($JNJ), Dignity Health, Kaiser Permanente, Reed Elsevier and General Electric ($GE). More

Suggested Articles

The Rady Children’s Institute for Genomic Medicine tapped Deloitte to help develop a network of flying drones to deliver genetic testing specimens.

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart.

The respiratory care company Vyaire Medical has brought on a new CEO, Gaurav Agarwal, following a year of new product launches.